Immunogenicity Following Administration of BNT162b2 and Ad26.COV2.S COVID-19 Vaccines in the Pregnant Population during the Third Trimester

Immunogenicity Following Administration of BNT162b2 and Ad26.COV2.S COVID-19 Vaccines in the Pregnant Population during the Third Trimester

Globally, COVID-19 vaccines are currently being used to prevent transmission and to reduce morbidity and death associated with SARS-CoV-2 infection. Current research reveals that vaccines such as BNT162b2 and Ad26.COV2.S are highly immunogenic and have high short-term effectiveness for most of the k...

Full description

Bibliographic Details
Main Authors: Ioana Mihaela Citu, Cosmin Citu, Florin Gorun, Ioan Sas, Larisa Tomescu, Radu Neamtu, Andrei Motoc, Oana Maria Gorun, Bogdan Burlea, Felix Bratosin, Daniel Malita
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Viruses
Subjects:
SARS-CoV-2
COVID-19
pregnancy vaccination
BNT162b2
Ad26.COV2.S
Online Access:https://www.mdpi.com/1999-4915/14/2/307

Internet

https://www.mdpi.com/1999-4915/14/2/307

Similar Items